監管
Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks
The European Commission approved an extension of the indication for MenQuadfi (Meningococcal Group A, C, W and Y conjugate vaccine) to include infants from six weeks of age, broadening the vaccine's addressable population in the EU.
大盤 開啟原文 ↗